↓ Skip to main content

Mifepristone for uterine fibroids

Overview of attention for article published in Cochrane database of systematic reviews, August 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
143 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mifepristone for uterine fibroids
Published in
Cochrane database of systematic reviews, August 2012
DOI 10.1002/14651858.cd007687.pub2
Pubmed ID
Authors

Mario Tristan, Leonardo J Orozco, Antonia Steed, Anggie Ramírez-Morera, Peter Stone

Abstract

Uterine fibroids are the most common benign uterine tumours present in women of reproductive age. Mifepristone (RU-486) competitively binds and inhibits progesterone receptors. Studies have suggested that fibroid growth depends on the sexual steroids. Mifepristone has been shown to decrease fibroid size. This review summarises the effects of mifepristone treatment on fibroids and the associated adverse effects as described in randomised controlled trials.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 141 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 18%
Student > Bachelor 21 15%
Researcher 16 11%
Student > Ph. D. Student 16 11%
Student > Postgraduate 13 9%
Other 25 17%
Unknown 26 18%
Readers by discipline Count As %
Medicine and Dentistry 75 52%
Psychology 9 6%
Nursing and Health Professions 8 6%
Agricultural and Biological Sciences 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 14 10%
Unknown 28 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 July 2019.
All research outputs
#3,980,986
of 14,104,163 outputs
Outputs from Cochrane database of systematic reviews
#6,885
of 10,849 outputs
Outputs of similar age
#26,914
of 98,843 outputs
Outputs of similar age from Cochrane database of systematic reviews
#64
of 119 outputs
Altmetric has tracked 14,104,163 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 10,849 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,843 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.